Keyphrases
Stereotactic Body Radiation Therapy
100%
Multiple Primary Lung Cancer
100%
Metachronous
57%
Overall Survival
42%
Synchronous multiple Primary Lung Cancer (SMPLC)
42%
Tumor
28%
Progression-free Survival
28%
Local Therapy
28%
High Risk
14%
Survival Rate
14%
Median Progression-free Survival
14%
Clinical Data
14%
Surgical Resection
14%
Medically Inoperable
14%
Local Control
14%
Local Treatment
14%
Living Patients
14%
Radiation Field
14%
Inoperable Patients
14%
Treatment Alternatives
14%
Synchronous Lesions
14%
Metachronous Lesion
14%
Therapeutic Dilemma
14%
Nursing and Health Professions
Lung Cancer
100%
Stereotactic Body Radiation Therapy
100%
Overall Survival
30%
Progression Free Survival
30%
Local Therapy
30%
Neoplasm
20%
Survival Rate
10%
Radiation Field
10%
Medicine and Dentistry
Lung Cancer
100%
Stereotactic Body Radiation Therapy
100%
Progression Free Survival
30%
Overall Survival
30%
Local Therapy
30%
Neoplasm
20%
Survival Rate
10%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Progression Free Survival
30%
Overall Survival
30%
Neoplasm
20%
Survival Rate
10%